Table 2. Contrasting results for CD44+/CD24- and prognosis.
This study otherwise showed that CD44+/CD24- had positive prognostic results
Author | Year | Study population | Findings |
Kim et al. [32] | 2011 | A retrospective study. Tissue microarray blocks of 643 cases of invasive breast carcinomas | CD44+/CD24- marker was taken as a positive prognostic subgroup in breast neoplasm |